PCC supports scientific studies that are likely to generate methods or products that will contribute to and improve the anti-doping landscape. Research priorities include:
- Developing methods of cost-effective testing to detect and deter the use of prohibited substances and methods.
- Developing novel testing protocols to detect and deter new or designer substances or methods used to evade detection (e.g., micor-dosing) for doping purposes.
- Improving existing chromatography-mass spectrometry and other analytical chemistry or biomedical methods to detect particular drugs.
- Developing new analytical methods to detect performance enhancing drugs not currently detectable.
- Examination of pharmacokinetic/pharmacodynamics of doping substances through human administration studies
- Critical reviews to support interpretation of laboratory data.
- The application of alternative specimens, (ex. oral fluid, dried blood/plasma spots) for testing and analysis.
- Discovery and validation of specific and sensitive biomarkers in urine and/or blood for the purposes of the Athlete Biological Passport (ABP) that aim to indirectly identify the use of doping substances or methods.
- Detection of prohibited gene doping, gene editing, gene silencing technologies, as well as the detection of prohibited stem cell therapies.
- Artificial intelligence, machine learning, and other related research that leads to optimization of anti-doping testing programs.
- Development of effective quantitative and qualitative measures of doping deterrence and education through well-designed survey methods applicable to multiple athlete domains and social science research.
Funding: no fixed limit ( average $130,000)
Duration: no fixed limit
Resקשrch Authority due dates: 26.7.26, 25.2.27
Pre application (required) due date: 1.8.26, 1.2.27
Full proposal due date: 1.9.26, 1.3.27
